End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 NZD | 0.00% | +2.91% | -28.38% |
Apr. 24 | Heartland Group Raises NZ$79 Million via Retail Entitlement Offer; Shares Down 3% | MT |
Apr. 10 | Heartland Group Completes Institutional Component of Entitlement Offer, Placement | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-28.38% | 585M | C | ||
+13.63% | 556B | C+ | ||
+11.52% | 298B | C+ | ||
+9.95% | 247B | C+ | ||
+21.50% | 210B | C | ||
+21.81% | 170B | B- | ||
+9.03% | 162B | B- | ||
+5.13% | 153B | C+ | ||
+0.01% | 139B | B- | ||
-10.52% | 138B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HGH Stock
- Ratings Heartland Group Holdings Limited